Rheumatology Network Newsletter

To view this email as a web page, click here.

Janssen Seeking Approval of New Treatment for Psoriatic Arthritis

Janssen is seeking FDA approval of guselkumab (Tremfya) for adults with active psoriatic arthritis. If approved, it would become the second IL-23 inhibitor in the U.S. market.

Nurse Practitioner Q&A: Psoriatic Arthritis 101

Psoriatic arthritis can appear in a variety of ways from nail disease to peripheral joint pain. But, there are a few hallmark signs that can send a rheumatologist or rheumatology nurse in the right direction. In this Q&A, Linda Grinnell-Merrick, NP, discusses the ins and outs of a psoriatic arthritis diagnosis.

Rheumatology Nurses Society Meeting Roundup: JIA, a Missed Diagnosis and More

From transitioning a pediatric rheumatology patient to adult care to re-evaluating a missed diagnosis, in this slideshow, we highlight some key presentations from the annual Rheumatology Nurses Society meeting held last month.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.